YERVOY for Malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 86 adverse event reports in the FDA FAERS database where YERVOY was used for Malignant melanoma.
Most Reported Side Effects for YERVOY
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 62 | 17.8% | 62 | 10 |
| Malignant neoplasm progression | 59 | 17.0% | 26 | 20 |
| Diarrhoea | 50 | 14.4% | 9 | 23 |
| Colitis | 29 | 8.3% | 8 | 17 |
| Rash | 24 | 6.9% | 1 | 3 |
| Pyrexia | 17 | 4.9% | 0 | 11 |
| Fatigue | 15 | 4.3% | 3 | 3 |
| Pruritus | 11 | 3.2% | 2 | 3 |
| Asthenia | 10 | 2.9% | 2 | 5 |
| Intestinal perforation | 10 | 2.9% | 5 | 5 |
| Nausea | 9 | 2.6% | 1 | 3 |
| Dehydration | 7 | 2.0% | 1 | 6 |
| Weight decreased | 7 | 2.0% | 2 | 3 |
| Adverse event | 6 | 1.7% | 0 | 3 |
| Atrial fibrillation | 6 | 1.7% | 3 | 5 |
Other Indications for YERVOY
Other Drugs Used for Malignant melanoma
NIVOLUMAB (10,599)
IPILIMUMAB (8,903)
DABRAFENIB (5,277)
TRAMETINIB DIMETHYL SULFOXIDE (3,841)
PEMBROLIZUMAB (3,261)
BINIMETINIB (2,613)
ENCORAFENIB (2,591)
VEMURAFENIB (2,548)
TRAMETINIB (1,448)
COBIMETINIB (1,324)